115 related articles for article (PubMed ID: 3942557)
1. Chlorpromazine inhibits arterial ACAT and reduces arterial cholesterol and cholesteryl ester accumulation in cholesterol-fed rabbits.
Bell FP; Schaub RG
Arteriosclerosis; 1986; 6(1):42-9. PubMed ID: 3942557
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of acyl-CoA cholesterol O-acyltransferase reduces the cholesteryl ester enrichment of atherosclerotic lesions in the Yucatan micropig.
Bocan TM; Mueller SB; Uhlendorf PD; Brown EQ; Mazur MJ; Black AE
Atherosclerosis; 1993 Mar; 99(2):175-86. PubMed ID: 8503946
[TBL] [Abstract][Full Text] [Related]
3. Hypolipidemic and antioxidant activity of the novel acyl-CoA:cholesterol acyltransferase (ACAT) inhibitor KY-455 in rabbits and hamsters.
Nakamura S; Kamiya S; Shirahase H; Kanda M; Yoshimi A; Tarumi T; Kurahashi K
Arzneimittelforschung; 2004; 54(2):102-8. PubMed ID: 15038459
[TBL] [Abstract][Full Text] [Related]
4. Preferential pharmacological inhibition of macrophage ACAT increases plaque formation in mouse and rabbit models of atherogenesis.
Perrey S; Legendre C; Matsuura A; Guffroy C; Binet J; Ohbayashi S; Tanaka T; Ortuno JC; Matsukura T; Laugel T; Padovani P; Bellamy F; Edgar AD
Atherosclerosis; 2001 Apr; 155(2):359-70. PubMed ID: 11254906
[TBL] [Abstract][Full Text] [Related]
5. The ACAT inhibitor avasimibe reduces macrophages and matrix metalloproteinase expression in atherosclerotic lesions of hypercholesterolemic rabbits.
Bocan TM; Krause BR; Rosebury WS; Mueller SB; Lu X; Dagle C; Major T; Lathia C; Lee H
Arterioscler Thromb Vasc Biol; 2000 Jan; 20(1):70-9. PubMed ID: 10634802
[TBL] [Abstract][Full Text] [Related]
6. Effect of trifluoperazine on certain arterial wall lipid-metabolizing enzymes inducing atherosclerosis in rhesus monkeys.
Mohindroo A; Ahluwalia P
Lipids; 1997 Aug; 32(8):867-72. PubMed ID: 9270979
[TBL] [Abstract][Full Text] [Related]
7. Effect of FR145237, a novel ACAT inhibitor, on atherogenesis in cholesterol-fed and WHHL rabbits. Evidence for a direct effect on the arterial wall.
Matsuo M; Ito F; Konto A; Aketa M; Tomoi M; Shimomura K
Biochim Biophys Acta; 1995 Dec; 1259(3):254-60. PubMed ID: 8541332
[TBL] [Abstract][Full Text] [Related]
8. Lack of correlation between ACAT mRNA expression and cholesterol esterification in primary liver cells.
Rea TJ; DeMattos RB; Homan R; Newton RS; Pape ME
Biochim Biophys Acta; 1996 Jan; 1299(1):67-74. PubMed ID: 8555254
[TBL] [Abstract][Full Text] [Related]
9. Influence of the acyl-CoA: cholesterol O-acyltransferase inhibitor, CL 277082, on cholesteryl ester accumulation in rabbit macrophage-rich granulomas and hepatic tissue.
Kelley JL; Suenram CA; Rozek MM; Schaffer SA; Schwartz CJ
Biochim Biophys Acta; 1988 May; 960(1):83-90. PubMed ID: 3358947
[TBL] [Abstract][Full Text] [Related]
10. Acyl-CoA:cholesterol acyltransferase inhibition reduces atherosclerosis in apolipoprotein E-deficient mice.
Kusunoki J; Hansoty DK; Aragane K; Fallon JT; Badimon JJ; Fisher EA
Circulation; 2001 May; 103(21):2604-9. PubMed ID: 11382731
[TBL] [Abstract][Full Text] [Related]
11. Influx, efflux, and hydrolysis of cholesteryl ester in atheromatous lesions of cholesterol-fed rabbits.
Hough JL; Zilversmit DB
Arteriosclerosis; 1986; 6(1):50-6. PubMed ID: 3942558
[TBL] [Abstract][Full Text] [Related]
12. Pharmacological properties of R-755, a novel acyl-CoA:cholesterol acyltransferase inhibitor, in cholesterol-fed rats, hamsters and rabbits.
Matsui Y; Horiuchi K; Yamamoto K; Kanai K
Jpn J Pharmacol; 2001 Apr; 85(4):423-33. PubMed ID: 11388647
[TBL] [Abstract][Full Text] [Related]
13. Pharmacological profile of F 12511, (S)-2',3', 5'-trimethyl-4'-hydroxy-alpha-dodecylthioacetanilide a powerful and systemic acylcoenzyme A: cholesterol acyltransferase inhibitor.
Junquero D; Oms P; Carilla-Durand E; Autin J; Tarayre J; Degryse A; Patoiseau J; Colpaert FC; Delhon A
Biochem Pharmacol; 2001 Jan; 61(1):97-108. PubMed ID: 11137714
[TBL] [Abstract][Full Text] [Related]
14. Direct effect of an acyl-CoA:cholesterol acyltransferase inhibitor, F-1394, on atherosclerosis in apolipoprotein E and low density lipoprotein receptor double knockout mice.
Chiwata T; Aragane K; Fujinami K; Kojima K; Ishibashi S; Yamada N; Kusunoki J
Br J Pharmacol; 2001 Aug; 133(7):1005-12. PubMed ID: 11487509
[TBL] [Abstract][Full Text] [Related]
15. Impaired mobilisation of cholesterol from stored cholesteryl esters in human (THP-1) macrophages.
Graham A; Angell AD; Jepson CA; Yeaman SJ; Hassall DG
Atherosclerosis; 1996 Feb; 120(1-2):135-45. PubMed ID: 8645354
[TBL] [Abstract][Full Text] [Related]
16. Importance of acyl-coenzyme A:cholesterol acyltransferase 1/2 dual inhibition for anti-atherosclerotic potency of pactimibe.
Kitayama K; Tanimoto T; Koga T; Terasaka N; Fujioka T; Inaba T
Eur J Pharmacol; 2006 Jul; 540(1-3):121-30. PubMed ID: 16730694
[TBL] [Abstract][Full Text] [Related]
17. N-[2-[N'-pentyl-(6,6-dimethyl-2,4-heptadiynyl)amino]ethyl]- (2-methyl-1-naphthylthio)acetamide (FY-087). A new acyl coenzyme a:cholesterol acyltransferase (ACAT) inhibitor of diet-induced atherosclerosis formation in mice.
Nagata Y; Yonemoto M; Iwasawa Y; Shimizu-Nagumo A; Hattori H; Sawazaki Y; Kamei T
Biochem Pharmacol; 1995 Mar; 49(5):643-51. PubMed ID: 7887979
[TBL] [Abstract][Full Text] [Related]
18. HL-004, the ACAT inhibitor, prevents the progression of atherosclerosis in cholesterol-fed rabbits.
Asami Y; Yamagishi I; Murakami S; Araki H; Tsuchida K; Higuchi S
Life Sci; 1998; 62(12):1055-63. PubMed ID: 9519807
[TBL] [Abstract][Full Text] [Related]
19. Membrane-active agents. Effect of various anesthetics and chlorpromazine on arterial lipid metabolism.
Bell FP; Hubert EV
Atherosclerosis; 1981 Jul; 39(4):517-25. PubMed ID: 7259830
[TBL] [Abstract][Full Text] [Related]
20. Effect of lacidipine on cholesterol esterification: in vivo and in vitro studies.
Bernini F; Canavesi M; Bernardini E; Scurati N; Bellosta S; Fumagalli R
Br J Pharmacol; 1997 Nov; 122(6):1209-15. PubMed ID: 9401788
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
